Betty Swartzentruber, now 90 years young, received life-saving care from the cardiac specialists and surgeons at MemorialCare ...

Visiongain has published a new report: Peripheral Vascular Device Market Report 2024-2034: Forecasts by Product (Stents (Bare ...

Profit margin: 19% (up from 13% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst ...

LeMaitre Vascular (NASDAQ:LMAT) just reported results for the first quarter of 2024.LeMaitre Vascular reported earnings per ...

LeMaitre Vascular (NASDAQ:LMAT) declares $0.16/share quarterly dividend, in line with previous. Forward yield 0.96% Payable May 30; for shareholders of record May 16; ex-div May 15. See LMAT Dividend ...

May 2, 2024 LeMaitre Vascular, Inc.  isn't one of the 30 most popular stocks among hedge funds at the end of the third ...

Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled ...

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Lemaitre Vascular (LMAT – Research Report), with a price target of $79.00. Michael Petusky has given his Buy ...

The $32 million investment has helped bring Alamance’s heart and vascular capabilities up to the same level as Greensboro – ...

Heading to Chicago for the 2024 Vascular Annual Meeting (VAM24)? Make your visit complete with a game at historic Wrigley Field! From all-inclusive suites to group and single game tickets, there are ...

KeyBanc analyst Brett Fishbin maintained a Hold rating on Lemaitre Vascular (LMAT – Research Report) today. The company’s shares closed yesterday at $66.77. According to TipRanks, Fishbin is a 2-star ...

The Vascular Institute of New York located in Borough Park since 1990 has recently been recognized as a Verified Outpatient ...